Earlier this year, President Obama went to Africa and issued this simple statement: "Africa's future is up to Africans." He highlighted the power of Christians and Muslims in Nigeria working side-by-side to end malaria.
Malaria isn't trendy, it isn't sexy, and it isn't on the cover of every magazine this week. But, in comparison with even the most villainous vampire in the "Twilight Saga", malaria wins one contest: it's definitely scarier.
Synthetic biology is a brand new area of biotechnology. The goal is to use genetic engineering technology to build brand new biological machines and processes de novo. It's an area that has tremendous potential.
Located at the epicenter of Rwanda's genocide, Ngeruka is a rural community that faces an array of health problems compounded by the fact that there is merely one small four-room health post servicing the entire community.
Nobody knows why Cambodia's malaria parasites are such buffed-up hyper-Darwinian winners. Some scientists think it's because the treatments have been used there so long that the parasites have a head-start.
Far from being a font of innovation, the drug market has become stagnant. Companies squander a fortune developing "me-too" drugs so they can take out a new patent and receive another avalanche of profits.